SIMS STRATEGIES, LLC

Lobbying for GLAXOSMITHKLINE, INC. · Pharmaceutical Company

Filing 1st Quarter - Report

1st Quarter (Jan 1 - Mar 31) 2026 · District of Columbia · Senate · $40,000.00 income · posted Apr 20, 2026

Lobbying activity 2

Pharmacy

Issues related to prescription drugs, vaccines, and Pharmacy Benefit Managers.

Medicare/Medicaid

Issues related to prescription drugs, vaccines, and Pharmacy Benefit Managers.

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.